1-2 of 2
Priti Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study

Matthew H. Taylor, Courtney B. Betts, Lauren Maloney, Eric Nadler, Alain Algazi, Michael J. Guarino, John Nemunaitis, Antonio Jimeno, Priti Patel, Veerendra Munugalavadla, Lin Tao, Douglas Adkins, Jerome H. Goldschmidt, Jr, Ezra E.W. Cohen, Lisa M. Coussens
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 903–914.
https://doi.org/10.1158/1078-0432.CCR-21-2547
Published: 01 March 2022
View article titled, Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
Open the PDF for Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study in another window
Includes: Supplementary data
Journal Articles

Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Anfal Alsadhan, Jean Cheung, Michael Gulrajani, Erika M. Gaglione, Pia Nierman, Ahmed Hamdy, Raquel Izumi, Elena Bibikova, Priti Patel, Clare Sun, Todd Covey, Sarah E.M. Herman, Adrian Wiestner
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 2800–2809.
https://doi.org/10.1158/1078-0432.CCR-19-3505
Published: 15 June 2020
View article titled, Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
Open the PDF for Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib in another window
Includes: Supplementary data